The Lancet Diabetes & Endocrinology最新文献

筛选
英文 中文
Copenhagen Declaration: a transformative vision for global diabetes 哥本哈根宣言:全球糖尿病的变革愿景
IF 44.5 1区 医学
The Lancet Diabetes & Endocrinology Pub Date : 2025-05-23 DOI: 10.1016/s2213-8587(25)00137-8
K M Venkat Narayan
{"title":"Copenhagen Declaration: a transformative vision for global diabetes","authors":"K M Venkat Narayan","doi":"10.1016/s2213-8587(25)00137-8","DOIUrl":"https://doi.org/10.1016/s2213-8587(25)00137-8","url":null,"abstract":"No Abstract","PeriodicalId":48790,"journal":{"name":"The Lancet Diabetes & Endocrinology","volume":"21 1","pages":""},"PeriodicalIF":44.5,"publicationDate":"2025-05-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144130249","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Artificial intelligence and diabetes: time for action and caution 人工智能和糖尿病:是时候采取行动并保持警惕了
IF 44.5 1区 医学
The Lancet Diabetes & Endocrinology Pub Date : 2025-05-22 DOI: 10.1016/s2213-8587(25)00142-1
Stefan R Bornstein, Amit Kumar Dey, Charlotte Steenblock, Viswanathan Mohan, Ranjit Mohan Anjana, Peter E H Schwarz
{"title":"Artificial intelligence and diabetes: time for action and caution","authors":"Stefan R Bornstein, Amit Kumar Dey, Charlotte Steenblock, Viswanathan Mohan, Ranjit Mohan Anjana, Peter E H Schwarz","doi":"10.1016/s2213-8587(25)00142-1","DOIUrl":"https://doi.org/10.1016/s2213-8587(25)00142-1","url":null,"abstract":"No Abstract","PeriodicalId":48790,"journal":{"name":"The Lancet Diabetes & Endocrinology","volume":"31 1","pages":""},"PeriodicalIF":44.5,"publicationDate":"2025-05-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144122398","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The obesity drug craze in Brazil 巴西的肥胖药物热潮
IF 44.5 1区 医学
The Lancet Diabetes & Endocrinology Pub Date : 2025-05-20 DOI: 10.1016/s2213-8587(25)00124-x
Heather Van Epps
{"title":"The obesity drug craze in Brazil","authors":"Heather Van Epps","doi":"10.1016/s2213-8587(25)00124-x","DOIUrl":"https://doi.org/10.1016/s2213-8587(25)00124-x","url":null,"abstract":"No Abstract","PeriodicalId":48790,"journal":{"name":"The Lancet Diabetes & Endocrinology","volume":"19 1","pages":""},"PeriodicalIF":44.5,"publicationDate":"2025-05-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144103927","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
China launches National Obesity Campaign 中国发起全国减肥运动
IF 44.5 1区 医学
The Lancet Diabetes & Endocrinology Pub Date : 2025-05-20 DOI: 10.1016/s2213-8587(25)00131-7
Zhaozhang Sun, Mengzi Sun, Wei Wei, Wen Peng, Youfa Wang
{"title":"China launches National Obesity Campaign","authors":"Zhaozhang Sun, Mengzi Sun, Wei Wei, Wen Peng, Youfa Wang","doi":"10.1016/s2213-8587(25)00131-7","DOIUrl":"https://doi.org/10.1016/s2213-8587(25)00131-7","url":null,"abstract":"No Abstract","PeriodicalId":48790,"journal":{"name":"The Lancet Diabetes & Endocrinology","volume":"135 1","pages":""},"PeriodicalIF":44.5,"publicationDate":"2025-05-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144103929","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mexico's junk food and soda taxes 墨西哥的垃圾食品和汽水税
IF 44.5 1区 医学
The Lancet Diabetes & Endocrinology Pub Date : 2025-05-16 DOI: 10.1016/s2213-8587(25)00140-8
Vijay Shankar Balakrishnan
{"title":"Mexico's junk food and soda taxes","authors":"Vijay Shankar Balakrishnan","doi":"10.1016/s2213-8587(25)00140-8","DOIUrl":"https://doi.org/10.1016/s2213-8587(25)00140-8","url":null,"abstract":"No Abstract","PeriodicalId":48790,"journal":{"name":"The Lancet Diabetes & Endocrinology","volume":"36 1","pages":""},"PeriodicalIF":44.5,"publicationDate":"2025-05-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144067255","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Correction to Lancet Diabetes Endocrinol 2025; 13: 307–20 《柳叶刀糖尿病内分泌》2025修订版;13: 307 - 20
IF 44.5 1区 医学
The Lancet Diabetes & Endocrinology Pub Date : 2025-05-16 DOI: 10.1016/s2213-8587(25)00158-5
{"title":"Correction to Lancet Diabetes Endocrinol 2025; 13: 307–20","authors":"","doi":"10.1016/s2213-8587(25)00158-5","DOIUrl":"https://doi.org/10.1016/s2213-8587(25)00158-5","url":null,"abstract":"<em>Jolliffe DA, Camargo CA Jr, Sluyter JD, et al. Vitamin D supplementation to prevent acute respiratory infections: systematic review and meta-analysis of stratified aggregate data. Lancet Diabetes Endocrinol 2025;</em> 13: <em>307–20</em>—In this Article, the affiliation for Prof Rachel E Neale has been corrected. This correction has been made to the online version as of May 16, 2025.","PeriodicalId":48790,"journal":{"name":"The Lancet Diabetes & Endocrinology","volume":"127 1","pages":""},"PeriodicalIF":44.5,"publicationDate":"2025-05-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144067385","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Surgery for the treatment of arterial hypertension in patients with unilateral adrenal incidentalomas and mild autonomous cortisol secretion (CHIRACIC): a multicentre, open-label, superiority randomised controlled trial 手术治疗单侧肾上腺偶发瘤和轻度自主皮质醇分泌(CHIRACIC)患者的高血压:一项多中心、开放标签、优势随机对照试验
IF 44.5 1区 医学
The Lancet Diabetes & Endocrinology Pub Date : 2025-05-12 DOI: 10.1016/s2213-8587(25)00062-2
Antoine Tabarin, Stéphanie Espiard, Timo Deutschbein, Laurence Amar, Delphine Vezzossi, Guido Di Dalmazi, Yves Reznik, Jacques Young, Rachel Desailloud, Bernard Goichot, Delphine Drui, Guillaume Assié, Hervé Lefebvre, Knut Mai, Frédéric Castinetti, Sandrine Laboureau, Massimo Terzolo, Amandine Ferriere, Aurore Georget, Eric Frison, Kathrin Zopf
{"title":"Surgery for the treatment of arterial hypertension in patients with unilateral adrenal incidentalomas and mild autonomous cortisol secretion (CHIRACIC): a multicentre, open-label, superiority randomised controlled trial","authors":"Antoine Tabarin, Stéphanie Espiard, Timo Deutschbein, Laurence Amar, Delphine Vezzossi, Guido Di Dalmazi, Yves Reznik, Jacques Young, Rachel Desailloud, Bernard Goichot, Delphine Drui, Guillaume Assié, Hervé Lefebvre, Knut Mai, Frédéric Castinetti, Sandrine Laboureau, Massimo Terzolo, Amandine Ferriere, Aurore Georget, Eric Frison, Kathrin Zopf","doi":"10.1016/s2213-8587(25)00062-2","DOIUrl":"https://doi.org/10.1016/s2213-8587(25)00062-2","url":null,"abstract":"&lt;h3&gt;Background&lt;/h3&gt;Adrenal incidentalomas are found in 3–10% of adults undergoing abdominal imaging. Of these, 30–50% are responsible for mild autonomous cortisol secretion (MACS), which is frequently associated with hypertension. The impact of adrenalectomy on hypertension in patients with unilateral incidentalomas and MACS remains uncertain. The aim of the CHIRACIC study was to prospectively assess the impact of surgical excision of the incidentaloma on blood pressure with a randomised trial combining accurate blood pressure measurement and standardisation of antihypertensive treatment.&lt;h3&gt;Methods&lt;/h3&gt;CHIRACIC was a multicentre, superiority, open-label, parallel, randomised controlled trial performed at 17 university hospitals in France, Italy, and Germany. Adults with hypertension with MACS entered a run-in phase to confirm hypertension with multiple home blood pressure measurements (HBPM) before blood pressure was normalised with standardised stepped-care antihypertensive treatment. Eligible participants were then randomly assigned (1:1) to adrenalectomy or conservative management. Randomisation was blocked (random block size of 4 and 6) and stratified by intensity of antihypertensive treatment. Participants were followed up for 13 months and systematic attempts were made to gradually reduce antihypertensive treatment. The primary endpoint was the proportion of normotensive participants using HBPM who reduced their antihypertensive treatment in the intention-to-treat population at study completion. Key secondary endpoints included 24 h ambulatory blood pressure measurement (ABPM), mean change in antihypertensive treatment, and the proportion of participants with antihypertensive treatment at study completion. This study was registered with &lt;span&gt;&lt;span&gt;ClinicalTrials.gov&lt;/span&gt;&lt;svg aria-label=\"Opens in new window\" focusable=\"false\" height=\"20\" viewbox=\"0 0 8 8\"&gt;&lt;path d=\"M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z\"&gt;&lt;/path&gt;&lt;/svg&gt;&lt;/span&gt;, &lt;span&gt;&lt;span&gt;NCT02364089&lt;/span&gt;&lt;svg aria-label=\"Opens in new window\" focusable=\"false\" height=\"20\" viewbox=\"0 0 8 8\"&gt;&lt;path d=\"M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z\"&gt;&lt;/path&gt;&lt;/svg&gt;&lt;/span&gt;, and is completed.&lt;h3&gt;Findings&lt;/h3&gt;Between April 9, 2015 and Nov 23, 2022, 78 patients were enrolled, and 52 eligible participants were randomly assigned to adrenalectomy (n=26, 23 underwent adrenalectomy and completed the study) or conservative management (n=26, 25 completed the study). The median age of participants was 63·3 years (IQR 57·4–68·2) and 36 (69%) were female. At study completion, a reduction in antihypertensive treatment with normal HBPM was observed in 12 (46%) of 26 participants treated with adrenalectomy and in four (15%) of 26 treated conservatively (adjusted risk difference [RD] 0·34 [95% CI 0·11 to 0·58]; p=0·0038). Similar results of smaller magnitude were observed for systolic blood pressure during 24 h ABPM. Ther","PeriodicalId":48790,"journal":{"name":"The Lancet Diabetes & Endocrinology","volume":"35 1","pages":""},"PeriodicalIF":44.5,"publicationDate":"2025-05-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143940266","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Adrenalectomy for mild autonomous cortisol secretion? 肾上腺切除术治疗轻度自主皮质醇分泌?
IF 44.5 1区 医学
The Lancet Diabetes & Endocrinology Pub Date : 2025-05-12 DOI: 10.1016/s2213-8587(25)00117-2
Andrea V Haas, Naomi D L Fisher, Gail K Adler
{"title":"Adrenalectomy for mild autonomous cortisol secretion?","authors":"Andrea V Haas, Naomi D L Fisher, Gail K Adler","doi":"10.1016/s2213-8587(25)00117-2","DOIUrl":"https://doi.org/10.1016/s2213-8587(25)00117-2","url":null,"abstract":"No Abstract","PeriodicalId":48790,"journal":{"name":"The Lancet Diabetes & Endocrinology","volume":"17 1","pages":""},"PeriodicalIF":44.5,"publicationDate":"2025-05-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143940267","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ultra-processed foods: yet another wake-up call 超加工食品:又一个警钟
IF 44.5 1区 医学
The Lancet Diabetes & Endocrinology Pub Date : 2025-05-09 DOI: 10.1016/s2213-8587(25)00139-1
{"title":"Ultra-processed foods: yet another wake-up call","authors":"","doi":"10.1016/s2213-8587(25)00139-1","DOIUrl":"https://doi.org/10.1016/s2213-8587(25)00139-1","url":null,"abstract":"No Abstract","PeriodicalId":48790,"journal":{"name":"The Lancet Diabetes & Endocrinology","volume":"1 1","pages":""},"PeriodicalIF":44.5,"publicationDate":"2025-05-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143931075","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Thyroid eye disease (Graves' orbitopathy): clinical presentation, epidemiology, pathogenesis, and management 甲状腺眼病(Graves眼病):临床表现、流行病学、发病机制和治疗
IF 44.5 1区 医学
The Lancet Diabetes & Endocrinology Pub Date : 2025-05-02 DOI: 10.1016/s2213-8587(25)00066-x
Wilmar M Wiersinga, Anja K Eckstein, Miloš Žarković
{"title":"Thyroid eye disease (Graves' orbitopathy): clinical presentation, epidemiology, pathogenesis, and management","authors":"Wilmar M Wiersinga, Anja K Eckstein, Miloš Žarković","doi":"10.1016/s2213-8587(25)00066-x","DOIUrl":"https://doi.org/10.1016/s2213-8587(25)00066-x","url":null,"abstract":"Thyroid eye disease (TED; also known as Graves' orbitopathy), causes swollen extraocular muscles and orbital fat. Mechanistically, TED involves lid retraction, oedema and redness of the eyelids and conjunctiva, proptosis, diplopia, and optic neuropathy. Investigation of TED involves assessment of disease activity (inflammation) and disease severity. TED is predominantly mild in 77% of cases, moderate-to-severe in 22%, and rarely sight-threatening in 1% of patients. While most patients with TED have Graves' hyperthyroidism, up to 5% are euthyroid or even hypothyroid. Risk factors include male sex, older age, smoking, diabetes, hypercholesterolaemia, duration of hyperthyroidism, radioactive iodine therapy, and the presence of thyrotropin receptor (TSHR) antibodies (detectable in more than 95% of patients and directly related to TED activity and severity). Genetic immunisation of mice with TSHR, but not with insulin-like growth factor-1 receptor (IGF-1R), provides a reliable animal model of TED, demonstrating that TSHR is the primary autoantigen in the disease. Crosstalk between TSHR and IGF-1R occurs via a β-arrestin scaffold. Teprotumumab, a human monoclonal antibody that blocks IGF-1R without binding to TSHR, has been shown to significantly improve outcomes in moderate-to-severe TED, including greater proptosis reduction compared with intravenous methylprednisolone. However, its disadvantages include side effects (eg, hearing loss in 30% of patients), a high cost, and a high relapse rate. Therefore, intravenous steroids remain the treatment of choice in many parts of the world. Tocilizumab, which blocks the interleukin-6 receptor, is an effective treatment option for patients with TED who are steroid-resistant. This Review further discusses alternative medications, surgical treatments, local measures, and the importance of quality-of-life assessments and multidisciplinary care.","PeriodicalId":48790,"journal":{"name":"The Lancet Diabetes & Endocrinology","volume":"34 1","pages":""},"PeriodicalIF":44.5,"publicationDate":"2025-05-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143901297","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信